TY - JOUR
AB - Subsequently to the publication of the above article, the authors have found that Fig. 4A on p. 1532 contained some errors. Owing to mistakes made during the preparation and revision of the manuscript, the invasion assay data images selected to show both the ‘Control’ and ‘shRNA2’ groups of the invasion and migration experiments were derived from the same original sources.
A corrected version of the Fig. 4, showing the correct data for the invasion and migration assay experiments with the Control and shRNA2 groups, is shown below. These inadvertent errors did not affect the conclusions reported in this paper, and all the authors agree with this Corrigendum. The authors thank the editor of Oncology Reports for presenting them with the opportunity to publish this Corrigendum, and apologize to the editor and to the readership of the journal for any inconvenience caused. [the original article was published in Oncology Reports 42: 1527-1538, 2019; DOI: 10.3892/or.2019.7257]
AD - Department of Pediatric Surgery, Children's Hospital of Fudan University, Shanghai 201102, P.R. China
Shanghai Key Lab of Birth Defect, Children's Hospital of Fudan University, Shanghai 201102, P.R. China
AU - Ye,Mujie
AU - Ma,Jing
AU - Liu,Baihui
AU - Liu,Xiangqi
AU - Ma,Duan
AU - Dong,Kuiran
DA - 2021/09/01
DO - 10.3892/or.2021.8156
IS - 3
JO - Oncol Rep
KW - long non‑coding RNA
neuroblastoma
competing endogenous RNA
PY - 2021
SN - 1021-335X
1791-2431
SP - 205
ST - [Corrigendum] Linc01105 acts as an oncogene in the development of neuroblastoma
T2 - Oncology Reports
TI - [Corrigendum] Linc01105 acts as an oncogene in the development of neuroblastoma
UR - https://doi.org/10.3892/or.2021.8156
VL - 46
ER -